Topics

Companies Related to "Global Gallbladder Cancer Therapeutics Market 2019 2023 Advent" [Most Relevant Company Matches] RSS

16:19 EDT 15th September 2019 | BioPortfolio

Here are the most relevant search results for "Global Gallbladder Cancer Therapeutics Market 2019 2023 Advent" found in our extensive corporate database of over 50,000 company records.

Showing "Global Gallbladder Cancer Therapeutics Market 2019 2023 Advent" Companies 1–25 of 10,000+

Relevant

Advent Consumer Healthcare, LLC

Advent Consumer Healthcare, LLC is dedicated to delivering innovative consumer products to help physicians and healthcare providers increase a patient’s overall awareness, involvement and compliance, as well as to facilitate the achievement of treatment goals. Founded in 2002 by seasoned healthcare executive Frank Alvino, Advent Consumer Healthcare, L...


Advent Venture Partners

Advent Venture Partners is one of the most experienced technology venture capital firms in the UK. Established in 1981 it invests in both the Information and Communications Technology and Life Sciences sectors. Now in its 25th year Advent has over £500 million under management from institutional investors across Europe and the USA.

GANYMED Pharmaceuticals AG

GANYMED Pharmaceuticals AG is developing monoclonal antibody therapeutics against solid tumors, where current therapies are poor and where there is an overriding medical need. The therapeutic efficacy of current solid cancer therapeutics is severely limited, because their molecular targets are elevated in a subset of a particular cancer but they are also found widely in normal tissues. In contrast...


Vitruvius Therapeutics Inc.

Vitruvias is a generic pharmaceutical company which utilizes domestic and international partnerships to develop, manufacture, and market technically difficult generic products. Founded in 2013, the company’s primarily focus is on products in the generic sterile injectable market, semi-solid market, and selected high-value oral solids The Company recei...

Advanced Cancer Therapeutics (ACT)

ACT is a for-profit private company dedicated to advancing novel therapeutics for the prevention and treatment of cancer. ACT has successfully established a unique and innovative business model with the University of Louisville’s James Graham Brown Cancer Center (Brown Cancer Center) whereby ACT is able to obtain exclusive worldwide licenses to novel ...

Bonnie J. Addario Lung Cancer Foundation (ALCF)

The Bonnie J. Addario Lung Cancer Foundation (ALCF) is one of the largest philanthropies (patient-founded, patient-focused, and patient-driven) devoted exclusively to eradicating Lung Cancer through research, early detection, education, and treatment. The Foundation's goal is to work with a diverse group of physicians, organizations, industry partners, ind...

Bonnie J Addario Lung Cancer Foundation

The Bonnie J. Addario Lung Cancer Foundation is one of the largest philanthropies (patient-founded, patient-focused, and patient-driven) devoted exclusively to eradicating Lung Cancer through research, education, early detection, genetic testing, drug discovery and patient-focused outcomes. The Foundation’s commitment to lung cancer patients is to col...

Avila Therapeutics, Inc.

Avila focuses on design and development of targeted covalent drugs to achieve best-in-class outcomes that cannot be achieved through traditional chemistries. This approach is called “protein silencing”. The company’s product pipeline has been built using its proprietary Avilomics™ platform and is currently focused on viral infection, cancer ...

Lava Therapeutics

Lava Therapeutics’ proprietary platform is focused on developing next generation γδ T cell engaging bispecific antibodies to treat cancer. Our first-in-class immuno-oncology approach activates Vγ9Vδ2 T cells upon binding to membrane-expressed tumor targets. Lava’s vision is to develop therapeutics for the curative treatment of cancer. Founde...

Cancer Therapeutics, Inc.TM

Founded in 1991, Cancer Therapeutics, Inc.TM (CTI) is a biotherapy company that is a leader in activated cell technology for cancer therapy. CTI's laboratory offers access to technologies grouped under the modality of Biotherapy. Biotherapy is based on treatments that enhance the patient's own immune system to attack the invading cancer. Research has shown cancer to be a highly individualized dise...

Clever Leaves

Clever Leaves, a vertically integrated Colombian company and legally licensed to cultivate medicinal cannabis, began its operations in Colombia in April 2016. Clever Leaves is cultivating under the Good Agricultural Collection Practices (“GACP”) certification process. In addition, the company obtained its European Good Manufacturing Practices (“EUGMP”) certification with a top...

BioCancell Therapeutics

BioCancell Therapeutics Inc. is a biopharmaceuticals corporation specializing in the development of Targeted Cancer Therapy for the treatment of numerous types of cancer. The Company's proprietary technology constitutes a novel paradigm for the targeted destruction of cancer cells, with no effect on normal surrounding tissue and no observed side effects, a...

Third Coast Therapeutics

Third Coast Therapeutics is a biotechnology company dedicated to developing orally active, small-molecule drugs that target the spread of cancer cells. Metastasis is estimated to cause 90 percent of cancer deaths. There are currently no approved drugs targeting this process. Third Coast’s lead candidate, 3crx98, is specifically designed to inhibit the movement of cancer cells without toxic s...

Celprogen Inc.

Celprogen Inc. is a global Stem Cell Research & Therapeutics company which is developing a proprietary portfolio of unique cancer therapeutics products and life science research tools that includes stem cell technologies for regenerative medicine, as well as bio-engineering products for tissue & organ transplants. Headquartered in San Pedro, California, Ce...

Rimon Therapeutics Ltd

Co-founded in 2000, by Dr. Michael May and Prof. Michael Sefton, Rimon Therapeutics, the Theramer™ company, develops advanced medical polymers that look beyond the advent of combination products (e.g., drug-eluting devices). Theramers™ are polymers that will give devices drug-like properties - without the drugs.Based in Toronto, Canada, Rimon Therapeutics aims to be a leader in the biomaterial...

CanLiv: The Hepatobiliary Cancers Foundation

A tax-exempt, not-for-profit charitable foundation incorporated in 2007, CanLiv: The Hepatobiliary Cancers Foundation is dedicated to improving lives of individuals diagnosed with cancer of the bile ducts, gallbladder and liver. The Foundation strives to provide accurate, current information and raise public awareness and attention to these orphan tumors, ...

Rational Therapeutics, Inc

Who are we?Rational Therapeutics, Inc. (RTI) is a free-standing research laboratory located in Long Beach, CA. Founded in 1993 by Dr. Robert Nagourney, a prominent hematologist/oncologist, Rational Therapeutics pioneers intelligent cancer therapies that are scientifically tailored for each individual patient. What do we do?Rational Therapeutics develops and provides cancer therapy recommendations,...

Abraxis BioScience, Inc.

Abraxis BioScience is a fully integrated global biotechnology company dedicated to the discovery, development and delivery of next-generation therapeutics and core technologies that offer patients safer and more effective treatments for cancer and other critical illnesses. The company's portfolio includes chemotherapeutic compound (ABRAXANE®), which is ...

Cytokine PharmaSciences, Inc.

Cytokine PharmaSciences, Inc. (CPSI), is a privately held, global biopharmaceutical company developing (i) controlled-release drug delivery products, primarily in the area of women’s health, and (ii) small molecule therapeutics in the areas of autoimmune diseases, inflammation and cancer. In addition to manufacturing a best-selling obstetric product currently on the market worldwide, the Compan...

Cristal Therapeutics

Cristal Therapeutics, established in Maastricht, focuses on the development of nanomedicines with improved therapeutic efficacy. The pipeline comprises of products based on drugs in development and also on the market, in combination with the patented CriPec® platform, for the treatment of various diseases, including cancer and chronic inflammatory disor...

Azaya Therapeutics, Inc.

Azaya Therapeutics (www.AzayaTherapeutics.com) is a San Antonio-based emerging pharmaceutical company whose innovative technology platform makes safer and more effective cancer treatments. Its unique and proprietary Protein Stabilized Nanoparticle (PSN™) platform addresses the significant problems associated with delivery of water insoluble drugs. Aza...

SpringWorks Therapeutics, Inc.

At SpringWorks Therapeutics, a clinical-stage biopharmaceutical company, we are driven to develop life-changing medicines for patients with severe rare diseases and cancer. Since our launch in 2017, we have worked to identify and advance promising science, beginning with our licensed clinical therapies from Pfizer Inc. We pioneer efficient pathways for dru...

Advent International Corporation

Advent is one of the leading private equity investors in North America. Since 1985, we have invested more than $1.5bn in over 275 companies across the US and Canada and have helped over 75 of these companies achieve successful IPOs. We pursue buyouts, recapitalizations and growth equity investments in selected growth industries. Target sectors include: Buyout/Private Equity – business and finan...

Seven and Eight Biopharmaceuticals Inc.

Seven and Eight Biopharmaceuticals Inc. is an Edison, NJ-based, clinical-stage biotech company focused on the development and commercialization of novel immunotherapies for cancer. The company specializes in TLR7/8 programs to treat cancer and has built a comprehensive global intellectual property portfolio in the category of toll-like receptor modulators. Managed by a seasoned team of profession...

Neon Therapeutics

Neon Therapeutics is an immuno-oncology company focused on developing novel therapeutics leveraging neoantigen biology to treat cancer. A neoantigen-based product engine will allow Neon to develop further treatment modalities including next-generation vaccines and T cell therapies targeting both personalized as well as shared neoantigens. Neon Therapeutics...


More From BioPortfolio on "Global Gallbladder Cancer Therapeutics Market 2019 2023 Advent"

Quick Search

Corporate Database Quicklinks